Targetting voltage-gated calcium channels in cardiovascular therapy
- 1 October 2000
- journal article
- Published by Elsevier in The Lancet
- Vol. 356 (9238) , 1287-1289
- https://doi.org/10.1016/s0140-6736(00)02807-5
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Nomenclature of Voltage-Gated Calcium ChannelsNeuron, 2000
- N-Type Calcium Channels Control Sympathetic Neurotransmission in Human Heart AtriumCirculation, 2000
- Postural hypotension following N-type Ca2+ channel blockade is amplified in experimental hypertensionJournal Of Hypertension, 2000
- Human vascular to cardiac tissue selectivity of L‐ and T‐type calcium channel antagonistsBritish Journal of Pharmacology, 1998
- Use of Intrathecal SNX-111, a Novel, N-Type, Voltage-Sensitive, Calcium Channel Blocker, in the Management of Intractable Brachial Plexus Avulsion PainThe Clinical Journal of Pain, 1997
- Voltage and pH dependent block of cloned N‐type Ca2+ channels by amlodipineBritish Journal of Pharmacology, 1997
- SELECTIVITY OF ω‐CONOTOXIN GVIA FOR N‐TYPE CALCIUM CHANNELS IN RAT ISOLATED SMALL MESENTERIC ARTERIESClinical and Experimental Pharmacology and Physiology, 1996
- Hemodynamic and Autonomic Reflex Effects of Chronic N-Type Ca2+ Channel Blockade with ω-Conotoxin GVIA in Conscious Normotensive and Hypertensive RabbitsJournal of Cardiovascular Pharmacology, 1995
- Selective inhibition of T-type Ca2+ channels by Ro 40-5967.Circulation Research, 1994